financetom
Business
financetom
/
Business
/
Icon, Advarra Collaborate to Develop Site Network Model for Clinical Trials
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Icon, Advarra Collaborate to Develop Site Network Model for Clinical Trials
Mar 24, 2026 6:12 AM

08:50 AM EDT, 03/24/2026 (MT Newswires) -- Icon (ICLR) said Tuesday it has signed a definitive partnership agreement with Advarra to develop a new connected site network model for clinical trials.

Under the partnership, Icon said it will integrate its clinical trial technology with Advarra's Clinical Trial Management Systems, electronic Investigator Site File, and eSource systems.

Icon said the partnership is aimed at lowering administrative friction, boosting study startup, and increasing participation in clinical trials.

Additionally, Icon said it will also receive operational intelligence from Advarra's data and AI platform, Braid, which will support protocol design, forecasting, study planning, research site identification, and feasibility decisions.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cogent Biosciences Submits New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors in US
Cogent Biosciences Submits New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors in US
Apr 1, 2026
08:54 AM EDT, 04/01/2026 (MT Newswires) -- Cogent Biosciences ( COGT ) said Wednesday it submitted a new drug application to the US Food and Drug Administration for bezuclastinib to treat gastrointestinal stromal tumors in patients previously treated with imatinib. The application was submitted under the FDA's Real-Time Oncology Review program based on positive results from a phase 3 trial,...
Correction: NovaGold Resources Posts Q1 FY26 Loss On Higher Expenditures at Donlin Gold, Which Remains Its
Correction: NovaGold Resources Posts Q1 FY26 Loss On Higher Expenditures at Donlin Gold, Which Remains Its "Primary Focus" For 2026
Apr 1, 2026
08:56 AM EDT, 04/01/2026 (MT Newswires) -- NovaGold Resources ( NG ) (NG.TO, NG), a development-stage company with no production, on Wednesday posted a fiscal Q1 2026 net loss of US$0.04 a share, reflecting higher expenditures at the Donlin Gold project in Alaska, which remains its primary focus for 2026. The company said it held approximately $392.5 million in cash...
Cal-Maine Foods Quarterly Results Fall Amid Lower Egg Prices; Expects Earnings to Stabilize
Cal-Maine Foods Quarterly Results Fall Amid Lower Egg Prices; Expects Earnings to Stabilize
Apr 1, 2026
08:54 AM EDT, 04/01/2026 (MT Newswires) -- Cal-Maine Foods ( CALM ) fiscal third-quarter results fell year over year amid lower egg prices, although the company expects earnings to stabilize in the long term. The egg producer on Wednesday posted net income of $1.06 a share for the three-month period ended Feb. 28, down 90% from a year earlier. The...
Jukebox Health Acquires Braided Health to Expand AI-Driven Integrated Care Platform for High-Needs Duals
Jukebox Health Acquires Braided Health to Expand AI-Driven Integrated Care Platform for High-Needs Duals
Apr 1, 2026
Augments Jukebox Health's home safety and independence ecosystem to help Managed Care Organizations modernize legacy care management systems and lower total cost of care for high-need, dual-eligible populations. NEW YORK, April 1, 2026 /PRNewswire/ -- Jukebox Health, a leader in advancing safety and independence at home, today announced the acquisition of Braided Health, a care management technology company serving high-need,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved